Evaluation and Comparison of Multi-Omics Data Integration Methods for Subtyping of Cutaneous Melanoma
-
Published:2022-12-13
Issue:12
Volume:10
Page:3240
-
ISSN:2227-9059
-
Container-title:Biomedicines
-
language:en
-
Short-container-title:Biomedicines
Author:
Amaro AdrianaORCID, Pfeffer Max, Pfeffer UlrichORCID, Reggiani Francesco
Abstract
There is a growing number of multi-domain genomic datasets for human tumors. Multi-domain data are usually interpreted after separately analyzing single-domain data and integrating the results post hoc. Data fusion techniques allow for the real integration of multi-domain data to ideally improve the tumor classification results for the prognosis and prediction of response to therapy. We have previously described the joint singular value decomposition (jSVD) technique as a means of data fusion. Here, we report on the development of these methods in open source code based on R and Python and on the application of these data fusion methods. The Cancer Genome Atlas (TCGA) Skin Cutaneous Melanoma (SKCM) dataset was used as a benchmark to evaluate the potential of the data fusion approaches to improve molecular classification of cancers in a clinically relevant manner. Our data show that the data fusion approach does not generate classification results superior to those obtained using single-domain data. Data from different domains are not entirely independent from each other, and molecular classes are characterized by features that penetrate different domains. Data fusion techniques might be better suited for response prediction, where they could contribute to the identification of predictive features in a domain-independent manner to be used as biomarkers.
Funder
Deutsche Forschungsgemeinschaft FONDAZIONE AIRC Italian Ministry of Health
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference54 articles.
1. The New NHGRI-EBI Catalog of Published Genome-Wide Association Studies (GWAS Catalog);MacArthur;Nucleic Acids Res.,2017 2. The Cancer Genome Atlas Research Network, Weinstein, J.N., Collisson, E.A., Mills, G.B., Shaw, K.R.M., Ozenberger, B.A., Ellrott, K., Shmulevich, I., Sander, C., and Stuart, J.M. (2013). The Cancer Genome Atlas Pan-Cancer Analysis Project. Nat. Genet., 45, 1113–1120. 3. Homologous Recombination Deficiency Status-Based Classification of High-Grade Serous Ovarian Carcinoma;Takaya;Sci. Rep.,2020 4. Dotolo, S., Esposito Abate, R., Roma, C., Guido, D., Preziosi, A., Tropea, B., Palluzzi, F., Giacò, L., and Normanno, N. (2022). Bioinformatics: From NGS Data to Biological Complexity in Variant Detection and Oncological Clinical Practice. Biomedicines, 10. 5. Sahnane, N., Carnevali, I., Formenti, G., Casarin, J., Facchi, S., Bombelli, R., Di Lauro, E., Memoli, D., Salvati, A., and Rizzo, F. (2020). BRCA Methylation Testing Identifies a Subset of Ovarian Carcinomas without Germline Variants That Can Benefit from PARP Inhibitor. Int. J. Mol. Sci., 21.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|